| BIOGEN INC. DL -,0005 |
| USA |
| Gesundheit |
| US09062X1037 / 789617 |
| IDP (Frankfurt) / BIIB (NASDAQ) |
| FRA:IDP, ETR:IDP, IDP:GR, NASDAQ:BIIB |
| S&P500 |
| https://www.biogen.com/ |
|
Biogen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers produc..
>Volltext.. |
| 25755.02 Mio. EUR |
| 27730.05 Mio. EUR |
| 8409.6 Mio. EUR |
| 2709.18 Mio. EUR |
| 1201.73 Mio. EUR |
| 8.19 EUR |
| 5747.99 Mio. EUR |
| 2963.12 Mio. EUR |
| 2269.45 Mio. EUR |
| 1.43 |
| -4.39% |
| -13.17% |
| - |
| - |
| - |
| - |
| BIOGEN |
| 13.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|